Trianon Scientific Communication

26/08/2026

Are your sustainability targets fuzzy-and quietly draining profits? We see it all the time: vague goals, siloed teams, and initiatives with no numbers attached. That’s waste. That’s margin erosion. We diagnose the root systemic barrier, apply Trianon’s P³ method, and turn guesswork into a measurable profit lift. Want a real example and a clear path forward? Visit https://wix.to/gzgeySu and let’s fix this together.

24/08/2026

29/06/2026

𝐘𝐨𝐮𝐫 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐬 𝐌𝐚𝐧𝐮𝐚𝐥 𝐃𝐨𝐞𝐬𝐧'𝐭 𝐈𝐧𝐜𝐥𝐮𝐝𝐞 𝐌𝐲 𝐒𝐤𝐢𝐧 - 𝐖𝐡𝐞𝐧 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐓𝐫𝐚𝐢𝐧𝐢𝐧𝐠 𝐌𝐢𝐬𝐭𝐚𝐤𝐞𝐬 𝐃𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝐟𝐨𝐫 𝐃𝐞𝐯𝐢𝐚𝐭𝐢𝐨𝐧

𝐌𝐞𝐞𝐭 𝐭𝐡𝐞 𝐬𝐩𝐞𝐚𝐤𝐞𝐫!

Dr. Nathalie Sène graduated from ULB in 2016. Since then she has built a practice most dermatologists do not have: skin allergy testing, darker phototypes, aesthetic medicine, all under one roof, all informed by the patients medical training tends to leave out of the textbook.

She sits on the Royal Belgian Society for Dermatology and Venerology, the Société Belge de Médecine Esthétique, and the Société Française des Lasers en Dermatologie.
She works at Brussels Skin Center in the European Quarter, a clinic that puts her in front of patients from every background the EU institutions bring to this city. That is not incidental to her expertise. It is the reason she has it.

On 30 June, she joins our roundtable at The Nine to talk about what happens when a diagnostic standard built on 12% of the population gets applied to the other 88%.

Details and registration:

📅 June 30th
🕣 7.30pm
🏩 The Nine
🎟️https://www.science-by-trianon.com/event-details/your-diagnosis-manual-doesnt-include-my-skin

26/06/2026

A super El Niño is forming in the Pacific. NOAA puts the odds above 60 percent it rivals 1997, the year that triggered billions in losses across agriculture, insurance, and shipping.

Here is the part your CSRD transition plan probably does not cover.
Most climate transition plans model gradual, linear change.

Average temperature rise, average sea level, average rainfall shift, all extrapolated in a straight line out to 2030 or 2050. El Niño does not move in a straight line. It is a six to twelve month spike layered on top of the existing 1.4 to 1.5 degrees of warming we already carry. It hits specific regions hard, fast, and asymmetrically. Drought flips to flood. Flood flips to drought. Fisheries collapse in one basin while another floods with stock.

A transition plan built entirely on long-term averages will say nothing useful about what happens to your supply chain this winter.

This matters for three reasons specific to CSRD and TCFD-aligned reporting.

One. Physical risk disclosure under ESRS E1 asks you to identify acute and chronic risks separately. El Niño is the textbook acute event. If your materiality assessment only lists chronic, gradual risks, an auditor is going to ask why you excluded the acute category that is forming in real time.

Two. Scenario analysis loses credibility fast if it cannot explain a known, named, currently forecast event. "We did not model El Niño" is not a defensible answer in front of a board or an assurance provider eighteen months from now.

Three. Supplier concentration risk. If your scope 3 mapping has not been cross-referenced against documented El Niño-sensitive geographies, you have a gap that is visible to anyone who knows where to look. Peru, Indonesia, Australia, the US Southwest, parts of East Africa.

The fix is not a new framework. It is one additional column in the risk register you already have: which of our top suppliers and facilities sit inside a known ENSO-sensitive zone, and what is the documented exposure if this event peaks as a strong or very strong El Niño this winter.

That column either exists in your file by the next board cycle, or it gets discovered by your auditor first.

Experts say climate pattern could supercharge extreme weather events and push temperatures to record highs

24/06/2026

[EVENT] 𝐘𝐨𝐮𝐫 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐬 𝐌𝐚𝐧𝐮𝐚𝐥 𝐃𝐨𝐞𝐬𝐧'𝐭 𝐈𝐧𝐜𝐥𝐮𝐝𝐞 𝐌𝐲 𝐒𝐤𝐢𝐧 - 𝐖𝐡𝐞𝐧 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐓𝐫𝐚𝐢𝐧𝐢𝐧𝐠 𝐌𝐢𝐬𝐭𝐚𝐤𝐞𝐬 𝐃𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝐟𝐨𝐫 𝐃𝐞𝐯𝐢𝐚𝐭𝐢𝐨𝐧

Medical textbooks show melanoma on white skin.

Rashes on white skin.

Inflammatory disease on white skin.
That training set represents 12% of the global population.
The result: a melanoma on Black skin does not match the photo in the manual. So it gets missed. Or caught late. Late is the difference between treatable and terminal.
On 30 June we are hosting a roundtable at The Nine, Brussels. Two dermatology specialists break down what standard training left out: how skin conditions present across different melanin levels, why diagnostic criteria delay care for Black patients, and what it takes to retrain a clinical baseline that was wrong from the start.
Bring your questions. Bring the diagnosis that never quite added up.

Details and registration:

📅 June 30th
🕣 7.30pm
🏩 The Nine
🎟️https://www.science-by-trianon.com/event-details/your-diagnosis-manual-doesnt-include-my-skin

22/06/2026

Brussels deregulated gene-edited crops to save the planet. Convenient that it also saves Bayer.
On 17 June, the EU approved new rules on gene-edited crops. Under 20 genetic modifications, treated like a conventional crop. No risk assessment. No traceability. No label on the food.
The reasons given are real. Climate adaptation. Food security. Competitiveness against the US and China. Nobody serious disputes any of that.
Here is the part worth sitting with. None of those three reasons required touching patent rights. NGT crops can still be patented. The traceability amendments failed. The patentability provisions did not. Funny, how that works out for the three companies large enough to file at scale, and considerably less funny for the seed cooperative that is not.
Two respected scientists disagree on whether "20 modifications" is even the right way to measure safety. Brussels picked a number, not a methodology. Sound familiar? It should. Every board approves a strategy this way. A pass mark that sounds rigorous enough that nobody asks who set it.

https://www.science-by-trianon.com/post/brussels-deregulated-gene-editing-to-save-the-planet-do-you-know-who-else-got-saved

Brussels deregulated gene-edited crops on 17 June 2026, citing climate adaptation, food security, and EU competitiveness. NGT-1 crops under 20 genetic modifications now skip risk assessment and traceability. But while labeling rules were dropped, patent rights for Bayer, Syngenta, and Corteva stayed...

01/06/2026

This week at the French Open, professional tennis players used bags of ice between sets just to keep playing. Not to win. To survive the match.

32 degrees in Paris. In May.

The same week, England published a government-backed climate report with one headline finding: the country is "built for a climate that no longer exists."

So are most corporate risk models.

Your company has warehouses, suppliers in southern Europe, logistics routes that depend on infrastructure designed for a different era. The continuity plan sitting in your risk register was written when a 32-degree May in Paris happened once in a generation.

That plan has not been updated. The climate has.

We were brought in to find what a pharmaceutical company's advisors had missed. Think of it like an X-ray. Their sustainability reports showed a healthy patient. The X-ray showed a fracture nobody had spotted. €40 million in hidden liability, sitting inside a supply chain, untouched across three audit cycles.

The fracture does not disappear because nobody looked for it. It just gets more expensive.

If you are a CFO, a CSO, or a CEO who suspects the X-ray has never been done, that is what a P3 Diagnostic is for. One conversation. We will tell you within the hour whether there is something worth looking at.

Book your P3 Diagnostic here:

24/05/2026

Five women. Five sectors. One question that leadership conversations rarely answer with precision.
What did you actually build that held?
Not which values guided the organization. What structure, what calculation, what decision was made before the pressure arrived, that meant the institution was still standing when it ended.

This Wednesday, Trianon co-founder Dr. Audrey-Flore Ngomsik joins the CEO of The Carter Center, the founder of JUMP, the director of CONCORD, and a Partner at Dalberg at The Nine Brussels.

The event is Women Leading Change. The topic is purpose-driven leadership in a volatile world.
Organizations that held over the last three years did not hold because their leaders had stronger values than the ones that collapsed. They held because someone ran the numbers early and built the structure around what those numbers revealed.
That is the work Trianon does. Across six sectors. In Europe, Africa, and the Middle East.

Wednesday, May 28. 19h00. The Nine, Brussels.
https://www.eventbrite.be/e/women-leading-change-tickets-1987634140219?aff=oddtdtcreator

13/04/2026

[EVENT] The "S" in ESG - When Human Capital Becomes Strategic, not Instrumental

Most companies know what the E in ESG costs them.
They have a number for carbon. They have a number for energy. They have a number for regulatory fines.
They have no number for the S.

They have a DEI report. They have a statement of commitment. They have a Head of People who reports to no one with budget authority. They have a workforce strategy that was written in 2021 and has not been tested against reality since.

The S in ESG is the most expensive letter in that acronym. It is also the one nobody is measuring.

Human capital either creates competitive advantage or it destroys it.
There is no neutral position.
The companies treating it as an HR function instead of a strategic asset are not managing it.
They are accumulating liability they have not priced.

Trianon Scientific Communication I am going to make that visible on Wednesday evening.
And LIV Consulting will show you how to fix it.

There are still some tickets available
📅 April 15th
🏨 The Nine
🕣 7.30pm
🎟️ https://www.science-by-trianon.com/event-details/the-s-in-esg

09/04/2026

Artemis II launched last week.
Four astronauts are on their way to the Moon for the first time in 53 years.

The pictures are breath-taking.

Victor Glover is the first Black person beyond low Earth orbit.
Christina Koch is the first woman.
Jeremy Hansen is the first non-US citizen.
All of this, in 2026.

The technology existed earlier.
But the room kept filling itself the same way. Same profile. Same blind spots. Same architecture

Now the harder question.

The Moon holds helium-3, a candidate fuel for nuclear fusion.
It holds rare earth elements that Earth extraction is depleting.
The 1967 Outer Space Treaty calls space a global commons. No nation owns it.
But a permanent lunar base, which is exactly what NASA is building toward, is a form of claim, treaty or not.

NASA has committed $18.3 billion through 2030, the majority flowing to two privately held companies. SpaceX and Blue Origin will use publicly funded infrastructure to establish commercial positions on a global commons with no international governance framework for resource extraction.

We are not against profit. Profit is how you prove the model works.
We are not against SpaceX or Blue Origin. Private innovation built what government procurement could not deliver in 53 years.

We are against the part where public risk and private reward share no governance architecture between them.

We have seen this before. Deep-sea mining. Arctic drilling. Satellite spectrum allocation.

The legal framework says one thing. The economic incentive structure moves faster. By the time regulation catches up, the commercial positions are entrenched and the public negotiating leverage is gone.
The people who bear the cost are rarely in the room when the architecture is designed.

Space program R&D produced water purification, solar panels, and medical technology that changed lives. The scientific value is real and documented.

The question is not whether value gets created. It is whether the governance structure ensures it gets distributed, or whether it gets captured by the two companies NASA now cannot operate without.

The governance of who benefits, who bears the cost, and who is in the room when those decisions are made, that architecture is still being written.
The companies that understand people, planet, profit, as a risk management framework rather than a reporting obligation will have a seat at that table.
Companies and governments that treat space resource governance as someone else's problem will not shape the rules. They will receive them.

The snap was taken aboard the Orion capsule by its commander, Reid Wiseman, as the crew head towards the Moon.